arf

(redirected from CDKN2A)
Also found in: Medical.

arf

(ɑːf)
n
a barking sound
References in periodicals archive ?
37,40) A variety of other genetic alterations can be found in IPMNs: LKB1/STK11, PK3CA, RNF43, p16/ CDKN2A, TP53, and SMAD4/DPC4.
29) The Cancer Genome Atlas has studied papillary renal cell carcinomas and characterized type I cancers with MET mutations and divided type II papillary RCCs into at least 3 subgroups with activation of the NRF2-ARE pathway, CDKN2A loss, and CIMP, the latter two conveying a poor prognosis (NEJM 2016).
The analysis centered on the activity of the KRAS, CDKN2A, SMAD4, and TP53 genes.
This study analysed protein expression and DNA alterations for the KRAS, CDKN2A, SMAD4, and TP53 genes by immunohistochemistry and next-generation sequencing in formalin-fixed, paraffin-embedded tumors in 356 patients with resected pancreatic adenocarcinoma who were treated at the Dana-Farber/Brigham and Women's Cancer Centre in Boston, University of Rochester Medical Centre, and Stanford Cancer Institute.
Besides, several tumor suppressor genes including DAPK (84%), CDKN2A (75%), MGMT (52%), and RFC (30%) are targeted by DNA hypermethylation.
Genes Tested AtP ALK APC ATM BAP1 BRCA2 BRIP1 BUB1B CDC73 CDH1 CEP57 CHEK2 CYLD DDB2 DICER1 ERCC3 ERCC4 ERCC5 EXT1 EXT2 FANCD2 FANCE FANCF FANCG FANCI GATA2 GPC3 HNF1A HOXB13 HRAS MLH1 MHS2 MSH6 MUTYH NBN PHOX2B PMS1 PMS2 PPM1D PRF1 RAD51D RBI RECQL4 RET RHBDF2 SDHC SDHD SLX4 SMAD4 SMARCA4 TP53 TSC1 TSC2 VHL WT1 BARD1 BLM BMPR1A BRCA1 CDK4 CDKN1C CDKN2A CEBPA DI53L2 EGFR EPCAM ERCC2 EZH2 FANCA FANCB FANCC FANCL FANCM FH FLCN KIT MAX MEN1 MET NF1 NF2 NSD1 PALB2 PRKAR1A PTCH1 PTEN RAD51C RUN XI SBDS SDHAF2 SDHB SMARCB1 STK11 5UFU TMEM127 WRN XPA XPC This chart shows all 98 cancer susceptible genes included in this new test.
This gene is known as CDKN2A (INK4a) encodes two separate protein products, p16 and p14, which are both negative regulators of cell cycle progression, which ultimately cause the development of cancer.
They found that lower DNA methylation at the CDKN2A gene, which regulates the production of fat cells, was associated with a greater risk of the child developing obesity in later life.
Para nuestro estudio, se seleccionaron genes supresores de tumores de diferentes vias metabolicas relacionados con el ciclo celular, entre ellos tenemos; Inhibidores de kinasas dependientes de ciclina, el CDKN2B (p15) y CDKN2A (p16), un inhibidor de las [beta] cateninas, el APC (Adenomatous Poliposis Coli), el gen hMLH1 (Human Mut Homologue 1) probablemente el mas importante de los genes reparadores de ADN genomico, relacionado con inestabilidad microsatelital y el gen CDH1 (Caderina E), que codifica una proteina transmembrana que participa en el complejo de moleculas de adhesion involucrada en la metastasis e invasion tumoral (8,9).
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
Por ejemplo, se ha reportado que la hipermetilacion de CDKN2A es un evento que ocurre muy temprano (fase premaligna); mientras que la metilacion de los genes RASSF1A, APC, ESR1, ABCB1, MT1G y HOXC9 esta asociada con NSCLC estadio I.
A gene called CDKN2A is more active in sunexposed facial skin than in samples taken from the buttocks.